| 1 | 86940-46-7 | Praeroside II | C20H24O10 | 424.4 | | |
| 2 | 86940-74-1 | L-Proline, 4-chloro-, methyl ester, cis- (9CI) | C6H10ClNO2 | 163.6021 | | |
| 3 | 86941-00-6 | (1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate | C7H10O3 | 142.15 | | |
| 4 | 86941-03-9 | Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2-methyl-1-propenyl)-, (1,1'-biphenyl)-3-ylmethyl ester, (1R,3R)- | C23H26O2 | 334.45 | | |
| 5 | 86941-06-2 | N-LIGNOCEROYLDIHYDRO-GLUCOCEREBROSIDE | C48H95NO8 | 814.278 | | |
| 6 | 86941-24-4 | Ro 31-1118 | | | | |
| 7 | 86941-27-7 | Norepinephrine | C19H21NO4 | 327.37 | | |
| 8 | 86941-59-5 | Benzo(6,7)phenanthro(3,4-B)oxirene-2,3-diol, 1A,2,3,11C-tetrahydro-6,11-dimethyl-, (1aalpha,2alpha,3beta,11calpha)- | C20H18O3 | 306.35512 | | |
| 9 | 86941-66-4 | D-erythro-Pentonamide, N-cyclohexyl-2-deoxy-2-methylene-4,5-O-(1-methylethylidene)- | C15H25NO4 | 283.36 | | |
| 10 | 86941-68-6 | D-threo-Pentonamide, N-cyclohexyl-2-deoxy-2-methylene-4,5-O-(1-methylethylidene)- | C15H25NO4 | 283.36 | | |
| 11 | 86941-88-0 | Phenol, 4-[1-[(trimethylsilyl)oxy]ethenyl]-, 1-acetate | C13H18O3Si | 250.37 | | |
| 12 | 86942-05-4 | Cobalt, bis[(2,3-butanedione dioximato)(1-)-N,N'](4-pyridinecarbonitrile-N1)(2,2,2-trifluoroethyl)-, (OC-6-12)- (9CI) | C16H19CoF3N6O4 | 475.29 | | |
| 13 | 86942-17-8 | Pyrazine, 2,5-dihydro-3,6-bis(methylthio)- | C6H10N2S2 | 174.29 | | |
| 14 | 86942-34-9 | 2,5-Piperazinedithione,1,4-dimethyl-(9CI) | C6H10N2S2 | | | |
| 15 | 86943-06-8 | Benzene, 1-(2,2-dimethyl-1,1-diphenylpropyl)-4-(2,2-dimethyl-1-phenylpropyl)- | C34H38 | 446.67 | | |
| 16 | 86943-79-5 | 9-EXOMETHYLAMINO-BENZOBICYCLO(2,2,1)-HEPTANE | C12H15N | 173.26 | | |
| 17 | 86943-82-0 | Propanedinitrile, 2-(4-nitrophenyl)-2-(1,2,3-trimethyl-2-cyclopropen-1-yl)- | C15H13N3O2 | 267.28 | | |
| 18 | 86943-85-3 | 9H-Fluorene-4,5-diamine, N4,N4,N5,N5-tetramethyl- | C17H20N2 | 252.35 | | |
| 19 | 86943-88-6 | 1,3-Cyclohexadiene, 1,4-bis(1,1-dimethylethyl)- | C14H24 | 192.34 | | |
| 20 | 86943-90-0 | 1,2-Cyclohexanediol, 1,4-bis(1,1-dimethylethyl)- | C14H28O2 | 228.37 | | |
| 21 | 86944-00-5 | 1,5-DITHIACYCLOOCTAN-3-OL | C6H12OS2 | 164.29 | | |
| 22 | 86944-11-8 | 4-Pyrimidineacetic acid, 1,6-dihydro-6-oxo-2-[(1-oxooctadecyl)amino]-, methyl ester | C25H43N3O4 | 449.63 | | |
| 23 | 86944-14-1 | 4-Pyrimidineacetic acid, α-chloro-2-[(2,2-dimethyl-1-oxopropyl)amino]-1,6-dihydro-6-oxo-, 4,4-dimethoxy-3-methyl-2-butenyl ester, (E)- (9CI) | C18H26ClN3O6 | 415.87 | | |
| 24 | 86944-15-2 | 4-Pyrimidineacetic acid, α,5-dibromo-2-[(2,2-dimethyl-1-oxopropyl)amino]-1,6-dihydro-6-oxo-, 4,4-dimethoxy-3-methyl-2-butenyl ester, (E)- (9CI) | C18H25Br2N3O6 | 539.22 | | |
| 25 | 86944-19-6 | 4-Pyrimidineacetic acid, 2-[(2,2-dimethyl-1-oxopropyl)amino]-1,6-dihydro-α,6-dioxo-, methyl ester | C12H15N3O5 | 281.26 | | |
| 26 | 86944-23-2 | 4(3H)-Pyrimidinone, 2-amino-6-(1,1-diethoxyethyl)- | C10H17N3O3 | 227.26 | | |
| 27 | 86944-24-3 | Acetamide, N-[4-(1,1-diethoxyethyl)-1,6-dihydro-6-oxo-2-pyrimidinyl]- | C12H19N3O4 | 269.3 | | |
| 28 | 86944-28-7 | Propanamide, N-[4-(1-ethoxyethenyl)-1,6-dihydro-6-oxo-2-pyrimidinyl]-2,2-dimethyl- | C13H19N3O3 | 265.31 | | |
| 29 | 86944-30-1 | Acetamide, N-[1,6-dihydro-6-oxo-4-[2-(phenylthio)acetyl]-2-pyrimidinyl]- | C14H13N3O3S | 303.34 | | |
| 30 | 86944-36-7 | Carbonic acid, 2-[2-(acetylamino)-1,6-dihydro-6-oxo-4-pyrimidinyl]-2,2-diethoxyethyl methyl ester | C14H21N3O7 | 343.33 | | |
| 31 | 86944-37-8 | Carbonic acid, 2-[2-(acetylamino)-1,6-dihydro-6-oxo-4-pyrimidinyl]-2-oxoethyl methyl ester | C10H11N3O6 | 269.21 | | |
| 32 | 86944-45-8 | Acetamide, N-[4-(2-bromo-1-ethoxyethenyl)-1,6-dihydro-6-oxo-2-pyrimidinyl]- | C10H12BrN3O3 | 302.12 | | |
| 33 | 86944-46-9 | Acetamide, N-[5-bromo-4-(2,2-dibromoacetyl)-1,6-dihydro-6-oxo-2-pyrimidinyl]- | C8H6Br3N3O3 | 431.86 | | |
| 34 | 86944-86-7 | (+)-3-Methoxy-3-(tetrahydro-5-methoxy-4-methylfuran-3-yl)acrylic acid | | | | |
| 35 | 86944-87-8 | CG 11 | C40H51NO15 | 785.835 | | |
| 36 | 86944-97-0 | Ethanethioic acid, anhydrosulfide with ethane(dithioic) acid | C4H6OS2 | 134.22 | | |
| 37 | 86945-03-1 | acetic acid: [6-(mercuriomethyl)-1,4-oxathian-2-yl]methylmercury | C10H16Hg2O5S | 649.47 | | |
| 38 | 86945-20-2 | 2-(1-Benzyl-piperidin-4-yl)-ethylaminehydrochloride | C14H23ClN2 | 254.79882 | | |
| 39 | 86945-23-5 | 3-(4-Chloro-phenyl)-butylamine | C10H14ClN | 183.68 | | |
| 40 | 86945-25-7 | Aminoethylbenzylpiperidine | C14H22N2 | 218.34 | | |
| 41 | 86945-27-9 | 1-BENZYL-4-CYANOMETHYL-PIPERIDINE-4-CARBONITRILE | C15 H17 N3 | 239.32 | 80.5-83.0 °C | |
| 42 | 86945-54-2 | N,N-dimethyl-3-(4'-bromophenyl)-1-indanamine | | | | |
| 43 | 86946-16-9 | N,N-dimethyl-3-(2',4'-dichlorophenyl)indanamine | | | | |
| 44 | 86946-41-0 | 1H-Inden-1-amine, 2,3-dihydro-N,N-dimethyl-3-phenyl-, hydrochloride, cis- | C17H19N.ClH | 273.8 | | |
| 45 | 869462-42-0 | Benzenemethanamine, α-(difluoromethyl)-4- methoxy-, (αS)- | C9H11F2NO | 187.19 | | |
| 46 | 869464-82-4 | 4-(2-AMINO-2-OXOETHOXY)-3-METHOXYBENZOIC ACID | C10H11NO5 | 225.2 | | |
| 47 | 869464-85-7 | Benzoic acid, 4-chloro-2-(2-oxo-1-pyrrolidinyl)- | C11H10ClNO3 | 239.65 | | |
| 48 | 869464-88-0 | 5-(1,1-DIOXIDOTETRAHYDROTHIEN-3-YL)-4-METHYL-4H-1,2,4-TRIAZOLE-3-THIOL | C7H11N3O2S2 | 233.31 | | |
| 49 | 869464-91-5 | 1-[4-(2-AMINO-1,3-THIAZOL-4-YL)PHENYL]PYRROLIDIN-2-ONE | C13H13N3OS | 259.33 | | |
| 50 | 869466-88-6 | Partially Hydrogenated Jojoba Oil | | | | |
| 51 | 869468-28-0 | Phenylmethyl N-[(1S)-3-[[(1S,2S)-2-hydroxy-1-methyl-2-phenylethyl]methylamino]-3-oxo-1-phenylpropyl]carbamate | C27H30N2O4 | 446.54 | | |
| 52 | 869468-34-8 | Carbamic acid, [(1R)-1-methyl-3-oxobutyl]-, 1,1-dimethylethyl ester (9CI) | C10H19NO3 | 201.26 | | |
| 53 | 869469-29-4 | Cyclopenta[g]-1-benzopyran-2(6H)-one, 7,8-dihydro-4-[[(1,2,3,4-tetrahydro-1-naphthalenyl)amino]methyl]- | C23H23NO2 | 345.43 | | |
| 54 | 869469-92-1 | [5-(2,5-dichlorophenyl)-2-methylfuran-3-yl]-morpholin-4-ylmethanone | C16H15Cl2NO3 | 340.2012 | | |
| 55 | 869470-04-2 | 5(4H)-Oxazolone, 4-(4-methoxyphenyl)-2-methyl- | C11H11NO3 | 205.21 | | |
| 56 | 869471-47-6 | WAY-325764 | C13H13N5O3 | 287.28 | | |
| 57 | 869471-49-8 | 7H-Purine-7-acetamide, N-[[(2,4-dimethylphenyl)amino]carbonyl]-1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo- | C18H20N6O4 | 384.39 | | |
| 58 | 869472-59-3 | 4-CYCLOPROPYL-4,5,6,7-TETRAHYDRO-THIENO[3,2-C]PYRIDINE | C10H13NS | 179.28 | | |
| 59 | 869472-60-6 | [(4-Methoxyphenyl)methyl](2,2,2-trifluoroethyl)amine | C10H12F3NO | 219.2 | | |
| 60 | 869472-64-0 | 3-[2-(4-FLUOROPHENYL)-1H-INDOL-3-YL]PROPANOIC ACID | C17H14FNO2 | 283.3 | | |
| 61 | 869472-66-2 | Acetamide, 2-chloro-N-cyclohexyl-N-[(4-fluorophenyl)methyl]- | C15H19ClFNO | 283.77 | | |
| 62 | 869472-68-4 | 2-[5-(thiophen-3-yl)-2H-1,2,3,4-tetrazol-2-yl]acetic Acid | C7H6N4O2S | 210.21 | | |
| 63 | 869474-43-1 | 2-Quinazolinepropanamide, 3,4-dihydro-N-[4-[[(2-methoxyphenyl)amino]carbonyl]phenyl]-4-oxo- | C25H22N4O4 | 442.47 | | |
| 64 | 869474-87-3 | 2(1H)-Isoquinolineacetamide, 3,4-dihydro-N-[2-[[[(4-methylphenyl)methyl]amino]carbonyl]phenyl]- | C26H27N3O2 | 413.51 | | |
| 65 | 869475-52-5 | 7-Fluoro-6-methoxy-quinazolin-4-ol | C9H7FN2O2 | 194.16 | | |
| 66 | 869476-25-5 | Methyl 2,3-di-O-benzyl-5-deoxy-5-iodo-D-xylofuranoside | | | | |
| 67 | 869477-96-3 | Olodaterol(BI-1744) hydrochloride | C21H26N2O5.HCl | 422.9 | | |
| 68 | 869478-09-1 | 8-acetyl-6-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one | C17H15NO4 | 297.31 | | |
| 69 | 869478-10-4 | Olodaterol Impurity 8 | C17H14ClNO4 | 331.75 | | |
| 70 | 869478-11-5 | 6-benzyloxy-8-((R)-2-chloro-1-hydroxy-ethyl)-4H-benzo[1,4]-oxazin-3-one | C17H16ClNO4 | 333.77 | | |
| 71 | 869478-12-6 | Olodaterol Impurity 10 | C17H15NO4 | 297.31 | | |
| 72 | 869478-13-7 | 8-[(1R)-1-Hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-6-(phenylmethoxy)-2H-1,4-benzoxazin-3(4H)-one | C28H32N2O5 | 476.56408 | | |
| 73 | 869478-15-9 | tert-butyl 4-(2-chloro-6-formylphenyl)piperazine-1-carboxylate | C16H21ClN2O3 | 324.8 | | |
| 74 | 869478-16-0 | tert-Butyl 4-(4-chloro-2-formylphenyl)tetrahydro-1(2H)-pyrazinecarboxylate | C16H21ClN2O3 | 324.8 | | |
| 75 | 86948-40-5 | 3H-Oxireno[8,8a]azuleno[4,5-b]furan-3,8(4aH)-dione, 5,6,9a,9b-tetrahydro-6-hydroxy-1,4a,7-trimethyl-, (3aR,4aS,6S,9aS,9bS)- (9CI) | C15H16O5 | 276.28 | | |
| 76 | 869481-92-5 | trans-3,4-difluoropyrrolidine hydrochloride | C4H8ClF2N | 143.5628264 | | |
| 77 | 869481-93-6 | 3-fluoro-4-hydoxy-N- Boc ... | C9H16FNO3 | 205.23 | | |
| 78 | 869481-94-7 | Pyrrolidine, 3,4-difluoro-, hydrochloride (1:1), (3S,4R)-rel- | C4H8ClF2N | 143.5628264 | | |
| 79 | 869482-93-9 | 1H-1,4-Diazepin-6-amine, hexahydro-6-methyl- | C6H15N3 | 129.2 | | |
| 80 | 869483-20-5 | 1(2H)-Naphthalenone, 2-(1,4-dioxan-2-ylmethyl)-3,4-dihydro- | C15H18O3 | | | |
| 81 | 869483-38-5 | Carbonochloridothioic acid,?S-3-butenyl ester | C5H7ClOS | 150.62 | | |
| 82 | 869485-36-9 | Dirithromycin EP impurity B | C29H56N2O9 | 576.77 | | |
| 83 | 869485-70-1 | (R)-1-Methylprop-2-enylaMine hydrochloride | C4H10ClN | 107.58 | | |
| 84 | 869486-54-4 | Spiro[2H-indene-2,3'-oxetane]-1,2',3-trione, 4'-(1,3-dihydro-1,3-dioxo-2H-inden-2-ylidene)- | C20H8O6 | 344.27 | | |
| 85 | 869486-64-6 | Benzenamine, 4-bromo-2-iodo-N-methyl- | C7H7BrIN | 311.95 | | |
| 86 | 869487-30-9 | (R,R)-Ph-BPE-Rh(acac) | C39H45O2P2Rh | 710.64 | | |
| 87 | 869487-35-4 | Butanoic acid, 3-oxo-, 2-[4-(2-hydroxy-2-methyl-1-oxopropyl)phenoxy]ethyl ester | C16H20O6 | 308.33 | | |
| 88 | 869487-76-3 | (S)-benzyl-(2,6-dimethyl-3-oxohept-1-en-4-yl)carbamate | C17H23NO3 | 289.37 | | |
| 89 | 869487-77-4 | benzyl ((3R,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl)carbamate | C17H25NO3 | 291.39 | | |
| 90 | 869487-79-6 | benzyl ((S)-4-methyl-1-((R)-2-methyloxiran-2-yl)-1-oxopentan-2-yl)carbamate | C17H23NO4 | 305.37 | | |
| 91 | 869487-82-1 | Benz[a]anthracen-1(2H)-one, 3,4-dihydro-7,8,12-trimethoxy-3-methyl-, (3S)- | C22H22O4 | 350.41 | | |
| 92 | 869488-92-6 | 1-Pyrrolidinecarboxylic acid, 2-[(3,3-difluoro-1-pyrrolidinyl)carbonyl]-4-hydroxy-, 1,1-dimethylethyl ester, (2S,4R)- | C14H22F2N2O4 | 320.33 | | |
| 93 | 869488-99-3 | 1-BENZHYDRYL-3-FLUORO-AZETIDINE HYDROCHLORIDE | C16H17ClFN | 277.76 | 138-140°C | |
| 94 | 869489-00-9 | (2S,4S)-1-Boc-2-(3,3-difluoropyrrolidine-1-carbonyl)-4-(1-piperazinyl)pyrrolidine | C18H30F2N4O3 | 388.4526064 | | |
| 95 | 869489-04-3 | (S)-4,4-difluoropyrrolidine-2-carbonitrile hydrochloride | C5H7ClF2N2 | 168.5722864 | | |
| 96 | 86949-00-0 | 2-Butene, 1-[(1,1-dimethyl-2-propen-1-yl)sulfonyl]-4-ethoxy-2-methyl- | C12H22O3S | 246.37 | | |
| 97 | 86949-75-9 | chlorooctadecylsilane | C18H39ClSi | 319.04076 | | |
| 98 | 86949-86-2 | 86949-86-2 | C14H13Cl | 216.71 | | |
| 99 | 869490-23-3 | Gosogliptin | C17H24F2N6O | 366.41 | | |
| 100 | 869490-47-1 | Gosogliptin Hydrochloride | C17H25ClF2N6O | 402.87 | | |
| 101 | 869491-11-2 | 1H-Imidazole-5-carboxamide, N-cyclopropyl- | C7H9N3O | | | |
| 102 | 869492-11-5 | (11bR,11'bR)-2,2'-[oxybis(methylene)]bis[N,N-dimethyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine | C46H38N2O5P2 | 760.77 | | |
| 103 | 869493-21-0 | 4-hydroxy-7-isopropyl-6-oxo-N-(3-(piperidin-1-yl)propyl)-6,7-dihydrothieno[2,3-b]pyridine-5-carboxamide | C19H27N3O3S | 377.5 | | |
| 104 | 869493-26-5 | NTC-942 | C19H28KN3O3S | 417.61 | | |
| 105 | 869493-47-0 | methyl4-hydroxy-7-isopropyl-6-oxo-6,7-dihydrothieno[2,3-b]pyridine-5-carboxylate | C12H13NO4S | 267.3 | | |
| 106 | 869493-51-6 | 4-Piperidinecarboxylic acid, 1-(3-aminopropyl)-, methyl ester | C10H20N2O2 | 200.28 | | |
| 107 | 869493-53-8 | 3-(4,4-difluoropiperidin-1-yl)propan-1-amine | C8H16F2N2 | 178.22 | | |
| 108 | 869493-55-0 | 3-(4,4-dimethylpiperidin-1-yl)propan-1-amine | C10H22N2 | 170.3 | | |
| 109 | 869493-57-2 | 3-((2R,6S)-2,6-dimethylpiperidin-1-yl)propan-1-amine | C10H22N2 | 170.3 | | |
| 110 | 869493-79-8 | 3-(4-Fluoro-3-methylphenyl)-2-methylprop-1-ene | C11H13F | 164.22 | | |
| 111 | 869493-97-0 | O-Desmethyl-Olodaterol | C20H24N2O5 | 372.42 | | |
| 112 | 869494-03-1 | N-Ethyl-N'-[7-(3-fluoro-2-pyridinyl)-5-[2-(1-hydroxy-1-methylethyl)-5-pyrimidinyl]-1H-benzimidazol-2-yl]urea | | | | |
| 113 | 869494-12-2 | 3,6-Diazabicyclo[3.1.1]heptan-2-one, 3,6-bis(phenylmethyl)- | C19H20N2O | 292.37 | | |
| 114 | 869494-13-3 | 3-benzyl-3,6-diazabicyclo[3.1.1]heptan-2-one | C12H14N2O | 202.25236 | | |
| 115 | 869494-14-4 | 3-benzyl-3,6-diazabicyclo[3.1.1]heptane | C12H16N2 | 188.26884 | | |
| 116 | 869494-15-5 | tert-Butyl 3-benzyl-3,6-diazabicyclo[3.1.1]heptane-6-carboxylate | C17H24N2O2 | 288.38466 | | |
| 117 | 869494-16-6 | 6-(tert-Butyloxycarbonyl)-3,6-diazabicyclo[3.1.1]heptane | C10H18N2O2 | 198.26 | | |
| 118 | 869494-18-8 | 3,6-Diazabicyclo[3.1.1]heptane, 6-(1-oxopropyl)- (9CI) | C8H14N2O | | | |
| 119 | 869494-20-2 | 3,6-Diazabicyclo[3.1.1]heptane, 3-(1-oxopropyl)- (9CI) | C8H14N2O | | | |
| 120 | 869495-24-9 | (S)-2-PIPERIDINYL-1,1,2-TRIPHENYLETHANOL | C25H27NO | 357.49 | 158 °C | |
| 121 | 869496-60-6 | 3-(3-chlorophenyl)isoxazole-5-carbaldehyde | C10H6ClNO2 | 207.61 | | |
| 122 | 869496-61-7 | 3-(2-BROMO-PHENYL)-ISOXAZOLE-5-CARBALDEHYDE | C10H6BrNO2 | 252.06 | | |
| 123 | 869496-62-8 | 3-(3-BROMO-PHENYL)-ISOXAZOLE-5-CARBALDEHYDE | C10H6BrNO2 | 252.06 | | |
| 124 | 869496-64-0 | 3-(4-NITRO-PHENYL)-ISOXAZOLE-5-CARBALDEHYDE | C10H6N2O4 | 218.17 | | |
| 125 | 869496-66-2 | 3-(4-Fluorophenyl)-5-methylisoxazole-4-carboxaldehyde | C11H8FNO2 | | 95-100 °C | |
| 126 | 869496-92-4 | 3,4,5-trimethyl-N-(3,4,5-trimethylphenyl)benzenamine | C18H23N | 253.38 | | |
| 127 | 869497-59-6 | 2,4-DibroMo-6-(1-phenylethyl)aniline | C14H13Br2N | 355.06772 | | |
| 128 | 869497-70-1 | BENZENEACETIC ACID, 3-BROMO-4-METHOXY-A-[(3,4,5-TRIMETHOXYPHENYL)METHYLENE]-, (AE)- | C19H19BrO6 | 423.25 | | |
| 129 | 869497-71-2 | BENZENEACETIC ACID, 3-HYDROXY-4-METHOXY-A-[(3,4,5-TRIMETHOXYPHENYL)METHYLENE]-, (AE)- | C19H20O7 | 360.36 | | |
| 130 | 869497-75-6 | 1-[(5-CHLORO-1H-BENZIMIDAZOL-2-YL)CARBONYL]-4-METHYLPIPERAZINE MALEATE | C17H19ClN4O5 | 394.80956 | | |
| 131 | 869499-38-7 | GSK-345931A sodium | C22H21ClNNaO3 | 405.85 | | |